To pool or not to pool? Screening of Chlamydia trachomatis and Neisseria gonorrhoeae in female sex workers: pooled versus single-site testing

Objectives As Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) are the most commonly reported STIs in Belgium and the majority of women infected are asymptomatic, targeted screening of patients in specified risk groups is indicated. To prevent long-term complications and interrupt transmission, extragenital samples should be included. As this comes with a substantial extra cost, analysis of a pooled sample from vaginal and extragenital sites could be a solution. In this study, we evaluated the feasibility of molecular testing for CT and NG in pooled versus single-site samples in a large cohort of female sex workers. Methods Women were sampled from three anatomical sites: a pharyngeal, a vaginal and a rectal swab. Each sample was vortexed, and 400 µL of transport medium from each sample site was pooled into an empty tube. NAAT was performed using the Abbott RealTime CT/NG assay on the m2000sp/rt system. Results We included 489 patients: 5.1% were positive for CT; 2.0% were positive for NG and 1.4% were coinfected, resulting in an overall prevalence of 6.5% (95% CI 4.5% to 9.1%) for CT and 3.5% (95% CI 2.0% to 5.5%) for NG. From the 42 patients positive on at least one non-pooled sample, only 5 gave a negative result on the pooled sample, resulting in a sensitivity of 94% (95% CI 79% to 99%) for CT and 82% (95% CI 57% to 96%) for NG. The missed pooled samples were all derived from single-site infections with low bacterial loads. The possibility of inadequate self-sampling as a cause of false negativity was excluded, as 4/5 were collected by the physician. Testing only vaginal samples would have led to missing 40% of CT infections and 60% of NG infections. Conclusions Pooling of samples is a cost-saving strategy for the detection of CT and NG in women, with minimal decrease in sensitivity. By reducing costs, more patients and more extragenital samples can be tested, resulting in higher detection rates.

[1]  T. Crucitti,et al.  Lymphogranuloma venereum is on the rise in Belgium among HIV negative men who have sex with men: surveillance data from 2011 until the end of June 2017 , 2018, BMC Infectious Diseases.

[2]  C. Kenyon,et al.  Take three, test one: a cross-sectional study to evaluate the molecular detection of Chlamydia trachomatis and Neisseria gonorrhoeae in pooled pharyngeal, anorectal and urine samples versus single-site testing among men who have sex with men in Belgium , 2018, Acta clinica Belgica.

[3]  L. Coorevits,et al.  Identifying a consensus sample type to test for Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium, Trichomonas vaginalis and human papillomavirus. , 2018, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[4]  I. Montesinos,et al.  Screening for Chlamydia trachomatis and Neisseria gonorrhoeae Infections in Men Who Have Sex With Men: Diagnostic Accuracy of Nucleic Acid Amplification Test on Pooled Urine, Anorectal, and Pharyngeal Specimens , 2017, Sexually transmitted diseases.

[5]  D. Speers,et al.  Detection of Neisseria gonorrhoeae and Chlamydia trachomatis from pooled rectal, pharyngeal and urine specimens in men who have sex with men , 2017, Sexually Transmitted Infections.

[6]  K. Holmes,et al.  Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014. , 2016, Morbidity and mortality weekly report. Surveillance summaries.

[7]  K. Radcliffe,et al.  UK national guideline for the management of infection with Chlamydia trachomatis , 2016 .

[8]  A. Copas,et al.  The “3 in 1” Study: Pooling Self-Taken Pharyngeal, Urethral, and Rectal Samples into a Single Sample for Analysis for Detection of Neisseria gonorrhoeae and Chlamydia trachomatis in Men Who Have Sex with Men , 2015, Journal of Clinical Microbiology.

[9]  L. Hoang,et al.  Self-Collected versus Clinician-Collected Sampling for Chlamydia and Gonorrhea Screening: A Systemic Review and Meta-Analysis , 2015, PloS one.

[10]  K. Workowski,et al.  Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  M. LeFevre Screening for Chlamydia and gonorrhea: U.S. Preventive Services Task Force recommendation statement. , 2014, Annals of internal medicine.

[12]  J. Papp,et al.  Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae--2014. , 2014, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[13]  D. Daniels,et al.  2013 UK National Guideline for the management of lymphogranuloma venereum , 2013, International journal of STD & AIDS.

[14]  M. Unemo,et al.  2012 European guideline on the diagnosis and treatment of gonorrhoea in adults , 2013, International journal of STD & AIDS.

[15]  D. Daniels,et al.  Clinical Effectiveness Group of the British Association for Sexual Health and HIV (CEG/BASHH) Guideline development group , 2013 .

[16]  J. Danielewski,et al.  Differing Neisseria gonorrhoeae Bacterial Loads in the Pharynx and Rectum in Men Who Have Sex with Men: Implications for Gonococcal Detection, Transmission, and Control , 2011, Journal of Clinical Microbiology.

[17]  N. Low,et al.  Screening and treatment to prevent sequelae in women with Chlamydia trachomatis genital infection: how much do we know? , 2010, The Journal of infectious diseases.

[18]  J. Parry,et al.  Self-taken pharyngeal and rectal swabs are appropriate for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae in asymptomatic men who have sex with men , 2008, Sexually Transmitted Infections.

[19]  M. Hankins,et al.  Self-sampling for oropharyngeal and rectal specimens to screen for sexually transmitted infections: acceptability among men who have sex with men , 2008, Sexually Transmitted Infections.

[20]  C. Black,et al.  The Natural History of Untreated Chlamydia trachomatis Infection in the Interval Between Screening and Returning for Treatment , 2008, Sexually transmitted diseases.

[21]  K. Workowski,et al.  Centers for Disease Control and Prevention sexually transmitted diseases treatment guidelines. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  R. Ness,et al.  Systematic Review: Noninvasive Testing for Chlamydia trachomatis and Neisseria gonorrhoeae , 2005, Annals of Internal Medicine.

[23]  Adrian Mindel,et al.  Recent advances: Sexually transmitted infections , 1998 .

[24]  K. Holmes,et al.  Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. , 1996, The New England journal of medicine.